Cargando…

Genetic Variants in Inflammation-Related Genes Are Associated with Radiation-Induced Toxicity Following Treatment for Non-Small Cell Lung Cancer

Treatment of non-small cell lung cancer (NSCLC) with radiotherapy or chemoradiotherapy is often accompanied by the development of esophagitis and pneumonitis. Identifying patients who might be at increased risk for normal tissue toxicity would help in determination of the optimal radiation dose to a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hildebrandt, Michelle A. T., Komaki, Ritsuko, Liao, Zhongxing, Gu, Jian, Chang, Joe Y., Ye, Yuanqing, Lu, Charles, Stewart, David J., Minna, John D., Roth, Jack A., Lippman, Scott M., Cox, James D., Hong, Waun Ki, Spitz, Margaret R., Wu, Xifeng
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2010
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2928273/ https://www.ncbi.nlm.nih.gov/pubmed/20811626 http://dx.doi.org/10.1371/journal.pone.0012402

Ejemplares similares

Inflammation-related genetic variants predict toxicities following definitive-radiotherapy for lung cancer
por: Pu, Xia, et al.
Publicado: (2014)

MiRNA-Related Genetic Variations Associated with Radiotherapy-Induced Toxicities in Patients with Locally Advanced Non–Small Cell Lung Cancer
por: Li, Rong, et al.
Publicado: (2016)

Inflammation-related Genetic Variations and Survival for Advanced Non-Small Cell Lung Cancer Receiving First-line Chemotherapy
por: Pu, Xia, et al.
Publicado: (2014)

What Would Be the Most Appropriate α/β Ratio in the Setting of Stereotactic Body Radiation Therapy for Early Stage Non-Small Cell Lung Cancer
por: Chi, Alexander, et al.
Publicado: (2013)

Long-term survival and toxicity outcomes of intensity modulated radiation therapy for the treatment of esophageal cancer: A large single-institutional cohort study
por: Shi, Anhui, et al.
Publicado: (2017)

Clinical outcome and predictors of survival and pneumonitis after stereotactic ablative radiotherapy for stage I non-small cell lung cancer
por: Chang, Joe Y, et al.
Publicado: (2012)

Socio-demographic, Clinical, and Genetic Determinants of Quality of Life in Lung Cancer Patients
por: Pierzynski, Jeanne A., et al.
Publicado: (2018)

Phase I Study of Celecoxib with Concurrent Irinotecan, Cisplatin, and Radiation Therapy for Patients with Unresectable Locally Advanced Non-Small Cell Lung Cancer
por: Komaki, Ritsuko, et al.
Publicado: (2011)

Accelerated hypofractionated radiation therapy compared to conventionally fractionated radiation therapy for the treatment of inoperable non-small cell lung cancer
por: Amini, Arya, et al.
Publicado: (2012)

Adding Erlotinib to Chemoradiation Improves Overall Survival but not Progression-Free Survival in Stage III Non-Small-Cell Lung Cancer
por: Komaki, Ritsuko, et al.
Publicado: (2015)

The Potential Role of Respiratory Motion Management and Image Guidance in the Reduction of Severe Toxicities Following Stereotactic Ablative Radiation Therapy for Patients with Centrally Located Early Stage Non-Small Cell Lung Cancer or Lung Metastases
por: Chi, Alexander, et al.
Publicado: (2014)

Postoperative Radiation Therapy for Non-Small Cell Lung Cancer and Thymic Malignancies
por: Gomez, Daniel R., et al.
Publicado: (2012)

FDG uptake correlates with recurrence and survival after treatment of unresectable stage III non-small cell lung cancer with high-dose proton therapy and chemotherapy
por: Xiang, Zuo-Lin, et al.
Publicado: (2012)

TGFβ1 Polymorphisms Predict Distant Metastasis–Free Survival in Patients with Inoperable Non-Small-Cell Lung Cancer after Definitive Radiotherapy
por: Yuan, Xianglin, et al.
Publicado: (2013)

Association of lung fluorodeoxyglucose uptake with radiation pneumonitis after concurrent chemoradiation for non-small cell lung cancer
por: Yue, Jinbo, et al.
Publicado: (2017)

Exclusion of elective nodal irradiation is associated with minimal elective nodal failure in non-small cell lung cancer
por: Sulman, Erik P, et al.
Publicado: (2009)

Dosimetric Selection for Helical Tomotherapy Based Stereotactic Ablative Radiotherapy for Early-Stage Non-Small Cell Lung Cancer or Lung Metastases
por: Chi, Alexander, et al.
Publicado: (2012)

Genetic variation in the TNF/TRAF2/ASK1/p38 kinase signaling pathway as markers for postoperative pulmonary complications in lung cancer patients
por: Hildebrandt, Michelle A. T., et al.
Publicado: (2015)

Common, germline genetic variations in the novel tumor suppressor BAP1 and risk of developing different types of cancer
por: Lin, Moubin, et al.
Publicado: (2017)

Modulators of radiation-induced cardiopulmonary toxicities for non-small cell lung cancer: Integrated cytokines, single nucleotide variants, and HBP systems imaging
por: Mukai-Sasaki, Yuki, et al.
Publicado: (2022)

Risk factors of local control in adrenal metastases treated by stereotactic body radiation therapy - a systematic review and meta-analysis
por: Liao, Xuehong, et al.
Publicado: (2023)

Genotypes and haplotypes of the VEGF gene and survival in locally advanced non-small cell lung cancer patients treated with chemoradiotherapy
por: Guan, Xiaoxiang, et al.
Publicado: (2010)

Activation of insulin-like growth factor 1 receptor in patients with non-small cell lung cancer
por: Kim, Jin-Soo, et al.
Publicado: (2015)

Assessing the robustness of passive scattering proton therapy with regard to local recurrence in stage III non-small cell lung cancer: a secondary analysis of a phase II trial
por: Zhu, Zhengfei, et al.
Publicado: (2014)

Association between Genetic Variants in DNA Double-Strand Break Repair Pathways and Risk of Radiation Therapy-Induced Pneumonitis and Esophagitis in Non-Small Cell Lung Cancer
por: Zhao, Lina, et al.
Publicado: (2016)

Dosimetric benefits of respiratory gating: a preliminary study
por: Butler, Laura E., et al.
Publicado: (2004)

Wnt Signaling Pathway Pharmacogenetics in Non-Small Cell Lung Cancer
por: Stewart, David J., et al.
Publicado: (2014)

Treatment of Brain Metastasis from Lung Cancer
por: Chi, Alexander, et al.
Publicado: (2010)

A validated miRNA profile predicts response to therapy in esophageal adenocarcinoma
por: Skinner, Heath D, et al.
Publicado: (2014)

Nomograms incorporating genetic variants in BMP/Smad4/Hamp pathway to predict disease outcomes after definitive radiotherapy for non‐small cell lung cancer
por: Yang, Ju, et al.
Publicado: (2018)

Radiotherapy for Thymic Carcinoma: Adjuvant, Inductive, and Definitive
por: Komaki, Ritsuko, et al.
Publicado: (2014)

Trends and Outcomes of Proton Radiation Therapy Use for Non–Small Cell Lung Cancer
por: Moreno, Amy C., et al.
Publicado: (2018)

Personalized Risk Assessment in Never, Light, and Heavy Smokers in a prospective cohort in Taiwan
por: Wu, Xifeng, et al.
Publicado: (2016)

Author Correction: Personalized Risk Assessment in Never, Light, and Heavy Smokers in a prospective cohort in Taiwan
por: Wu, Xifeng, et al.
Publicado: (2020)

Outcomes of re-irradiation for brain recurrence after prophylactic or therapeutic whole-brain irradiation for small cell lung Cancer: a retrospective analysis
por: Suzuki, Ryoko, et al.
Publicado: (2018)

Different dietary patterns and reduction of lung cancer risk: A large case-control study in the U.S.
por: Tu, Huakang, et al.
Publicado: (2016)

Genetic associations of T cell cancer immune response-related genes with T cell phenotypes and clinical outcomes of early-stage lung cancer
por: Wang, Qinchuan, et al.
Publicado: (2020)

In Vivo Delivery of miR-34a Sensitizes Lung Tumors to Radiation Through RAD51 Regulation
por: Cortez, Maria Angelica, et al.
Publicado: (2015)

Cancer associated macrophage-like cells and prognosis of esophageal cancer after chemoradiation therapy
por: Gironda, Daniel J., et al.
Publicado: (2020)

A Public Health Perspective on Preventing and Controlling the Spread of Coronavirus Disease 2019
por: Wu, Xifeng, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_e750l8i87ffluusbq0snt90tre